This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
The master regulator MYC controls cell behavior by regulating the activity of many other genes, some of which can promote cancer. It does so with the help of enhancers (and super-enhancers) that allow MYC to bind and activate other genes. The relationship between MYC and its enhancers is complex, so Dr. Guo is seeing how MYC levels affect enhancers and how enhancer activity affects MYC levels. He has found evidence for a feedback loop that may be responsible for MYC-induced activation of cancer-promoting genes, and he’s continuing to identify and characterize other MYC-associated enhancers. This knowledge may help stimulate efforts to address MYC’s pro-cancer effects through both prevention and treatment.
Whitehead Institute for Biomedical Research | All Cancers, Leukemia, Lymphoma, Multiple Myeloma | 2015 | Richard A. Young, Ph.D.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).